Masaru Morita
-
- Gastric Cancer Management and Outcomes 67
- Metastasis and carcinoma case studies 20
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 22
- Colorectal Cancer Treatments and Studies 20
- Cancer-related Molecular Pathways 15
- Surgery top 1%
- Esophageal Cancer Research and Treatment 93
- Esophageal and GI Pathology 59
- Cancer Research top 2%
- Otorhinolaryngology top 2%
-
- Genetic factors in colorectal cancer 26
- Co-authors
- Yoshihiko MaeharaEiji OkiYoshihiro KakejiAkinori EgashiraHiroshi SaekiEriko TokunagaKoji AndoHiroyuki Kuwano
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Masaru Morita
286 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 1.8k
- Surgery 2.7k
- Cancer Research 743
- Otorhinolaryngology 200
Countries citing papers authored by Masaru Morita
This map shows the geographic impact of Masaru Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Morita more than expected).
Fields of papers citing papers by Masaru Morita
This network shows the impact of papers produced by Masaru Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Morita. The network helps show where Masaru Morita may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaru Morita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2020 | 3 | |
| 5 | 2016 | 2 | |
| 6 | 2016 | 0 | |
| 7 | 2015 | 29 | |
| 8 | 2015 | 26 | |
| 9 | Significance of accurate human epidermal growth factor receptor-2 (HER2) evaluation as a new biomarker in gastric cancer. | 2014 | 9 |
| 10 | 2013 | 51 | |
| 11 | シリコーン椎間板を使用した腹腔鏡胃手術に関係する,新規に開発された肝臓後退法:Φ形技法 | 2013 | 0 |
| 12 | 2013 | 16 | |
| 13 | 2013 | 6 | |
| 14 | 2012 | 1 | |
| 15 | 2011 | 3 | |
| 16 | 2011 | 1 | |
| 17 | 2009 | 18 | |
| 18 | 2006 | 38 | |
| 19 | Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis. | 2006 | 11 |
| 20 | [Clinicopathologic study on the mode and degree of invasion of the trachea by thyroid carcinoma]. | 1987 | 2 |
About Masaru Morita
Masaru Morita is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Surgery, Oncology and Pathology and Forensic Medicine, having authored 306 papers that have together received 5.9k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (93 papers), Gastric Cancer Management and Outcomes (67 papers), Esophageal and GI Pathology (59 papers), Genetic factors in colorectal cancer (26 papers), Pancreatic and Hepatic Oncology Research (22 papers), Metastasis and carcinoma case studies (20 papers), Colorectal Cancer Treatments and Studies (20 papers) and Cancer-related Molecular Pathways (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.8k citations), Surgery (2.7k citations), Cancer Research (743 citations) and Otorhinolaryngology (200 citations). Masaru Morita has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Yoshihiko Maehara, Eiji Oki, Yoshihiro Kakeji, Akinori Egashira, Hiroshi Saeki, Eriko Tokunaga, Koji Ando, Hiroyuki Kuwano, Noriaki Sadanaga and Hiroshi Saeki. Their work appears in journals such as Surgery Today, Annals of Surgical Oncology, Esophagus, Journal of Clinical Oncology and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.